ZIVO Bioscience Enters into Exchange Agreements with Investors

On January 9, 2025, ZIVO Bioscience, Inc. (NASDAQ: ZIVO) disclosed in a recent Form 8-K filing that its board of directors has authorized the company to initiate a series of Exchange Agreements with accredited investors who are signatories to License and Co-Development Participation Agreements with ZIVO. The Exchange Agreements follow previous Participation Agreements that occurred […]

Leave a Reply

Your email address will not be published.

ZIVO Bioscience Enters into Exchange Agreements with Investors

On January 9, 2025, ZIVO Bioscience, Inc. (NASDAQ: ZIVO) disclosed in a recent Form 8-K filing that its board of directors has authorized the company to initiate a series of Exchange Agreements with accredited investors who are signatories to License and Co-Development Participation Agreements with ZIVO. The Exchange Agreements follow previous Participation Agreements that occurred […]

Leave a Reply

Your email address will not be published.

ZIVO Bioscience Enters into Exchange Agreements with Investors

On January 9, 2025, ZIVO Bioscience, Inc. (NASDAQ: ZIVO) disclosed in a recent Form 8-K filing that its board of directors has authorized the company to initiate a series of Exchange Agreements with accredited investors who are signatories to License and Co-Development Participation Agreements with ZIVO. The Exchange Agreements follow previous Participation Agreements that occurred […]

Leave a Reply

Your email address will not be published.

Previous post Wild praised for stepping up as Kirill Kaprizov inches closer to returning
Next post Short Interest in Calamos Convertible and High Income Fund (NASDAQ:CHY) Rises By 147.5%